KD Logo

Enliven Therapeutics Inc (ELVN) receives a Buy rating from Mizuho

Enliven Therapeutics Inc’s recently made public that its PRESIDENT AND CEO Kintz Samuel unloaded Company’s shares for reported $0.2 million on Apr 25 ’24. In the deal valued at $16.89 per share,12,000 shares were sold. As a result of this transaction, Kintz Samuel now holds 0 shares worth roughly $0.0.

Then, Heyman Richard A. sold 1,270 shares, generating $25,383 in total proceeds. Upon selling the shares at $19.99, the Director now owns 137,155 shares.

Before that, Ballal Rahul D. sold 53,400 shares. Enliven Therapeutics Inc shares valued at $1,279,068 were divested by the Director at a price of $23.95 per share. As a result of the transaction, Ballal Rahul D. now holds 22,341 shares, worth roughly $0.39 million.

Mizuho initiated its Enliven Therapeutics Inc [ELVN] rating to a Buy in a research note published on April 09, 2024; the price target was $34. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late March with a ‘”a Buy”‘ rating.

Price Performance Review of ELVN

On Tuesday, Enliven Therapeutics Inc [NASDAQ:ELVN] saw its stock fall -2.25% to $17.39. Over the last five days, the stock has gained 0.12%. Enliven Therapeutics Inc shares have risen nearly 25.65% since the year began. Nevertheless, the stocks have fallen -8.67% over the past one year. While a 52-week high of $26.00 was reached on 04/11/24, a 52-week low of $9.80 was recorded on 03/15/24. SMA at 50 days reached $17.14, while 200 days put it at $15.07. A total of 0.79 million shares were traded, compared to the trading of 0.28 million shares in the previous session.

Levels Of Support And Resistance For ELVN Stock

The 24-hour chart illustrates a support level at 17.04, which if violated will result in even more drops to 16.69. On the upside, there is a resistance level at 18.05. A further resistance level may holdings at 18.71. The Relative Strength Index (RSI) on the 14-day chart is 47.97, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.93, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.76%. Stochastics %K at 14.87% indicates the stock is a buying.

Most Popular

[the_ad id="945"]